|Bid||0.00 x 800|
|Ask||0.00 x 900|
|Day's range||149.57 - 152.58|
|52-week range||149.09 - 319.32|
|Beta (5Y monthly)||0.79|
|PE ratio (TTM)||18.08|
|Earnings date||03 Nov 2021 - 08 Nov 2021|
|Forward dividend & yield||N/A (N/A)|
|1y target est||266.04|
The Yahoo Finance panel discusses the continued drag going on amongst Chinese stocks as concerns over Evergrande’s impact continue to influence the market.
The thought of a Lehman Brothers-esque collapse in China sent U.S. investors running for the exits Monday. The Dow Jones Industrial Average (^DJI) sank 614 points, while the S&P 500 (^GSPC) fell 75 points and the Nasdaq Composite (^IXIC) plunged 330 points. It was the market’s worst one day slide in months and shattered an extended stretch of calm for stocks. The S&P 500 hadn’t fallen more than 1% since mid-August. Investors were rattled by news that the major Chinese real estate developer, Evergrande, is close to defaulting on a mountain of debt and worried that Beijing will allow the company to crash and burn.
September's been a rough month for the stock market, and on Monday, the S&P 500 had its worst day in months, falling 1.7%. Instead, it may be time to load up on three growth stocks near their 52-week lows, including Jazz Pharmaceuticals (NASDAQ: JAZZ), Activision Blizzard (NASDAQ: ATVI), and Alibaba Group Holding (NYSE: BABA). Healthcare company Jazz Pharmaceuticals is trading at around $130 and has been falling more than 20% year to date, while the S&P 500 has risen by 16%.